Schear Capital raises TSM stake as institutional buyers rotate into Taiwan semiconductors at $185

Schear Investment Advisers LLC increased its position in Taiwan Semiconductor Manufacturing Company during the fourth quarter, according to its 13F filing disclosed this week. The Connecticut-based firm now holds a larger stake in the chipmaker trading near $185 per share, joining a documented shift among institutional allocators rotating into Taiwan equities after two quarters of China-heavy exposure.

The filing arrives as HSBC's most recent flow data confirms Asian and emerging-market funds are moving capital from mainland Chinese technology names into Taiwan semiconductors. The bank's prime services desk reported the rotation began in late December and accelerated through January, with TSM capturing the majority of incremental Taiwan inflows. Schear's disclosed increase aligns with this pattern—measured institutional buying rather than momentum chasing, executed across multiple quarters as TSM's Arizona fab timeline firmed and hyperscaler capital expenditure guidance remained intact.

The move matters because it reflects allocator conviction on three specific points. First, the Arizona facility's $40 billion construction remains on schedule for 2025 production despite permitting delays that pushed initial timelines. Second, Nvidia's Blackwell ramp requires TSM's N3E node at volumes no other foundry can match, creating six-quarter revenue visibility that extends into 2026. Third, geopolitical risk is now priced—TSM trades at a 15% discount to its five-year average forward multiple despite gross margins holding above 53%, a spread sophisticated buyers recognize as entry-grade mispricing. Schear's increase suggests the firm believes that gap closes as U.S. election risk fades and Washington's semiconductor policy stabilizes around domestic production incentives rather than export restrictions.

The broader EM rotation HSBC documented tells the second part of the story. Chinese technology exposure peaked in November when Beijing's stimulus rhetoric was loudest. Since then, funds have trimmed Alibaba, Tencent, and domestic chip names while adding Taiwan positions. TSM, MediaTek, and ASML's Taiwan customer base absorbed $4.2 billion in net inflows across December and January, according to HSBC's aggregated flow data. That rotation continues. The mechanics are simple: allocators needed EM and Asia exposure for portfolio mandates, chose China for beta, and are now shifting to Taiwan for earnings certainty. Schear's filing is one visible node in a much larger reallocation.

Operators should watch three follow-on signals. TSM reports first-quarter earnings in mid-April—management's commentary on N3 yield rates and Blackwell-related CapEx will clarify whether hyperscaler demand holds through summer. Arizona's permitting resolution is expected before June, which would lock the 2025 production start and likely trigger another wave of domestic-focused institutional buying. Finally, if the EM-to-Taiwan rotation persists through March, TSM's forward multiple should compress toward 18x, erasing the current geopolitical discount and putting the stock closer to $210 without requiring earnings surprises.

Schear manages roughly $850 million in assets. The firm does not chase narratives. Its fourth-quarter increase in TSM—disclosed now, executed then—marks the kind of position-building that precedes rather than follows breakouts.